HSD3B1 Variants Linked With Outcomes of Prostate Cancer Treatments - Cancer Network

[unable to retrieve full-text content]HSD3B1 Variants Linked With Outcomes of Prostate Cancer Treatments  Cancer Network

HSD3B1 genotype may be a predictive biomarker for the use of androgen deprivation therapy (ADT) or abiraterone in Japanese men with prostate cancer, ...



https://ift.tt/2Xsc8gf

Comments

Popular posts from this blog

Q&A

Sentinel lymph node biopsy: What cancer patients should know

I Wish I Didn't Need an Oncologist at All, But I'm Thankful for the One ...